Vestibular Schwannoma in the Precision Medicine Era: An Updated Narrative Review of Molecular Insights, Imaging Biomarkers, and Evolving Management Strategies

Vestibular schwannoma (VS) care is increasingly shaped by molecular and imaging advances that complement conventional size- and symptom-based decision-making. Recent multi-omic studies, including single-cell and spatial transcriptomics and methylation profiling, reveal biologically distinct Schwann cell states and microenvironmental programs that may help explain heterogeneous growth, hearing decline, and treatment...

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

This narrative review consolidates evolving molecular and imaging biomarker data for vestibular schwannoma management; clinicians should note emerging precision medicine frameworks but no immediate practice change is warranted pending prospective validation of biomarkers.

✦ Why It Matters ✦

As multi-omic profiling and advanced imaging mature, integrating molecular biomarkers into vestibular schwannoma management decisions could shift clinical practice away from a one-size-fits-all watch-and-wait or treat paradigm.

✦ Key Points ✦

01Reviews molecular (genomic/proteomic) insights driving precision medicine approaches to vestibular schwannoma.
02Covers emerging imaging biomarkers that may better predict tumor growth or treatment response.
03Discusses evolving management strategies including observation, radiation, and surgery.
04Situates vestibular schwannoma within a broader multi-omic research context.
05Published in the Journal of International Advanced Otology 2026.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Multi-omic research is providing new molecular insights and imaging biomarkers that could refine vestibular schwannoma management strategies.

opinionpartially supported

✦ Research metadata ✦

PMID: 42732637
DOI: 10.65717/iao.2026.262358.
Journal: Journal of International Advanced Otology
Publication type: review
Evidence level: 5
Population: Patients with vestibular schwannoma (narrative review; no primary patient cohort)
Intervention: Precision medicine approaches including molecular profiling and imaging biomarkers

Primary outcomes

Molecular insights into vestibular schwannoma biology; Imaging biomarker utility; Management strategy outcomes

✦ Related stories ✦

PubMed·Journal article·Research (general)·8w ago

Impaired speech-in-noise perception in individuals with a history of hearing symptoms after noise exposure

Audiologists should consider supplementing standard audiograms with speech-in-noise testing for patients reporting noise-exposure symptoms, as normal thresholds alone may miss clinically meaningful hearing dysfunction consistent with cochlear synaptopathy (hidden hearing loss).

PubMed·Journal article·Research (general)·3mo ago

Effects of Hearing Intervention on Cognitive Function in Patients with Presbycusis: A Systematic Review and Meta-Analysis

This systematic review and meta-analysis provides the strongest available evidence that hearing intervention positively impacts cognitive function in older adults with age-related hearing loss; audiologists should use these findings to counsel patients and reinforce the...

PubMed·Journal article·Research (general)·3mo ago

The Genetic Causes of Auditory Neuropathy: A Systematic Review

Genetic testing for auditory neuropathy is clinically meaningful because the causative gene can influence cochlear implant candidacy and expected outcomes; audiologists should advocate for genetic workup in confirmed auditory neuropathy cases.

PubMed·Journal article·Research (general)·2mo ago

Hearing Loss in Adults With Diabetes and Prediabetes: A Systematic Review and Meta-Analysis

Audiologists should consider routine hearing screening for adult patients with known diabetes or prediabetes, as this meta-analysis provides strong epidemiological evidence linking both conditions to increased prevalence and severity of hearing loss.

PubMed·Clinical trial·Research (general)·3d ago

Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

are secondary and exploratory — audiologists should not change practice based on these biomarker findings alone, but the study adds biological plausibility to hearing intervention as a potential tool for brain health preservation.

PubMed·Preprint·Research (general)·2mo ago

Older adults show overexaggerated and larger noise-related degradation in their neural tracking of speech

This finding suggests age-related declines in how the brain tracks speech in noise go beyond peripheral hearing loss; audiologists should be cautious attributing all speech-in-noise difficulty in older adults to the audiogram alone, though the preprint has not yet been...

PubMed·Journal article·Research (general)·2mo ago

ATP6V1B1-A Novel Genetic Association Between Pendred Imaging Phenotype and Renal Tubular Acidosis

Audiologists and otolaryngologists encountering patients with the Pendred imaging phenotype (enlarged vestibular aqueduct/cochlear malformation pattern) should consider ATP6V1B1 mutation testing and prompt referral for renal evaluation, as co-existing distal renal tubular...

PubMed·Journal article·Research (general)·3w ago

Normative Ranges for Auditory Brainstem Response Wave I Amplitude: A Potential Diagnostic Indicator of Cochlear Deafferentation

These normative ranges for ABR Wave I amplitude could support clinical identification of cochlear synaptopathy in patients with normal audiograms but auditory complaints; audiologists should consider this as a supplementary diagnostic tool pending further validation in diverse...